International Journal of Gastroenterology

Archive

Submit a Manuscript

Publishing with us to make your research visible to the widest possible audience.

Propose a Special Issue

Building a community of authors and readers to discuss the latest research and develop new ideas.

Empirical Research on the Anti-Inflammatory, Antibacterial, and Mucosal Protective Effects of Agarwood Based on the Oral and Intestinal Microenvironment

Objective: To investigate the effects of chemical substances contained in agarwood on the body's inflammatory response, oxidative stress, oral and intestinal micro-ecology, as well as their role in various mucosal diseases, such as recurrent aphthous ulcer (RAU) and inflammatory bowel disease (IBD). Materials and Methods: By reviewing and summarizing literature from the past decade on agarwood and its related chemical components composition, as well as their effects on RAU and IBD, we explore the role of agarwood in the body and its relationship with mucosal-related diseases. Results: The Specific components in agarwood, such as sesquiterpenes, flavonoids, etc., can regulate the body's inflammatory response and oxidative stress levels through various signaling pathways, thereby affecting the mucosal status of the oral and intestinal cavity, such as influencing the expression of tight junction proteins between epithelial cells to restore mucosal barrier permeability. Conclusion: Agarwood can down-regulate the inflammatory response by inhibiting various signaling pathways, mainly NF-κB, reduce oxidative stress by decreasing ROS expression, improve the mucosal barrier in the oral and intestinal cavity, and simultaneously impact the improvement of oral and intestinal micro-ecology. It plays a certain controlling role in mucosal-damaged diseases such as IBD and RAU, laying the foundation for the transformation, development, and upgrading of the agarwood industry.

Agarwood, Anti-Inflammatory, Flavonoids

APA Style

Yi-Nan Zhang, Zi-Lin Wang, Xiang Guo, Xue-Jing Lin, Hao-Yi Duan, et al. (2023). Empirical Research on the Anti-Inflammatory, Antibacterial, and Mucosal Protective Effects of Agarwood Based on the Oral and Intestinal Microenvironment. International Journal of Gastroenterology, 7(2), 49-53. https://doi.org/10.11648/j.ijg.20230702.12

ACS Style

Yi-Nan Zhang; Zi-Lin Wang; Xiang Guo; Xue-Jing Lin; Hao-Yi Duan, et al. Empirical Research on the Anti-Inflammatory, Antibacterial, and Mucosal Protective Effects of Agarwood Based on the Oral and Intestinal Microenvironment. Int. J. Gastroenterol. 2023, 7(2), 49-53. doi: 10.11648/j.ijg.20230702.12

AMA Style

Yi-Nan Zhang, Zi-Lin Wang, Xiang Guo, Xue-Jing Lin, Hao-Yi Duan, et al. Empirical Research on the Anti-Inflammatory, Antibacterial, and Mucosal Protective Effects of Agarwood Based on the Oral and Intestinal Microenvironment. Int J Gastroenterol. 2023;7(2):49-53. doi: 10.11648/j.ijg.20230702.12

Copyright © 2023 Authors retain the copyright of this article.
This article is an open access article distributed under the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1. Akintoye SO, Greenberg MS. Recurrent aphthous stomatitis. Dent Clin North Am. 2014 Apr; 58 (2): 281-97.
2. Li C, Wu Y, Xie Y, Zhang Y, Jiang S, Wang J, Luo X, Chen Q. Oral manifestations serve as potential signs of ulcerative colitis: A review. Front Immunol. 2022 Sep 29; 13: 1013900.
3. Xun Z, Zhang Q, Xu T, Chen N, Chen F. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles. Front Microbiol. 2018 May 30; 9: 1136.
4. Nassar M, Tabib Y, Capucha T, Mizraji G, Nir T, Pevsner-Fischer M, Zilberman-Schapira G, Heyman O, Nussbaum G, Bercovier H, Wilensky A, Elinav E, Burstyn-Cohen T, Hovav AH. GAS6 is a key homeostatic immunological regulator of host-commensal interactions in the oral mucosa. Proc Natl Acad Sci U S A. 2017 Jan 17; 114 (3): E337-E346.
5. Aarabi G, Heydecke G, Seedorf U. Roles of Oral Infections in the Pathomechanism of Atherosclerosis. Int J Mol Sci. 2018 Jul 6; 19 (7): 1978.
6. Wang S, Yu Z, Wang C, Wu C, Guo P, Wei J. Chemical Constituents and Pharmacological Activity of Agarwood and Aquilaria Plants. Molecules. 2018 Feb 7; 23 (2): 342.
7. Dahham SS, Tabana YM, Iqbal MA, Ahamed MB, Ezzat MO, Majid AS, Majid AM. The Anticancer, Antioxidant and Antimicrobial Properties of the Sesquiterpene β-Caryophyllene from the Essential Oil of Aquilaria crassna. Molecules. 2015 Jun 26; 20 (7): 11808-29.
8. Watanabe T, Fujiwara Y, Chan FKL. Current knowledge on non-steroidal anti-inflammatory drug-induced small-bowel damage: a comprehensive review. J Gastroenterol. 2020 May; 55 (5): 481-495.
9. Zhen Y, Zhang H. NLRP3 Inflammasome and Inflammatory Bowel Disease. Front Immunol. 2019 Feb 28; 10: 276.
10. Han Y, Huang W, Meng H, Zhan Y, Hou J. Pro-inflammatory cytokine interleukin-6-induced hepcidin, a key mediator of periodontitis-related anemia of inflammation. J Periodontal Res. 2021 Aug; 56 (4): 690-701.
11. Osuch S, Laskus T, Berak H, Perlejewski K, Metzner KJ, Paciorek M, Radkowski M, Caraballo Cortés K. Decrease of T-cells exhaustion markers programmed cell death-1 and T-cell immunoglobulin and mucin domain-containing protein 3 and plasma IL-10 levels after successful treatment of chronic hepatitis C. Sci Rep. 2020 Sep 29; 10 (1): 16060.
12. Pingili RB, Challa SR, Pawar AK, Toleti V, Kodali T, Koppula S. A systematic review on hepatoprotective activity of quercetin against various drugs and toxic agents: Evidence from preclinical studies. Phytother Res. 2020 Jan; 34 (1): 5-32.
13. Lin C. F., Leu Y. L., Al-Suwayeh S. A., Ku M. C., Hwang T. L., Fang J. Y. Anti-inflammatory activity and percutaneous absorption of quercetin and its polymethoxylated compound and glycosides: The relationships to chemical structures. Eur. J. Pharm. Sci. 2012; 47: 857–864.
14. Fan Y, Mao R, Yang J. NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer. Protein Cell. 2013 Mar; 4 (3): 176-85.
15. Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Res. 2014 Feb 1; 74 (3): 852-61.
16. Han J. Overview of sesquiterpenes and chromones of agarwood originating from four main species of the genus Aquilaria. RSC Adv. 2019 Jan 30; 9 (8): 4113-4130.
17. Pérez-Torres I, Castrejón-Téllez V, Soto ME, Rubio-Ruiz ME, Manzano-Pech L, Guarner-Lans V. Oxidative Stress, Plant Natural Antioxidants, and Obesity. Int J Mol Sci. 2021 Feb 11; 22 (4): 1786.
18. Qiu Z, He Y, Ming H, Lei S, Leng Y, Xia ZY. Lipopolysaccharide (LPS) Aggravates High Glucose-and Hypoxia/Reoxygenation-Induced Injury through Activating ROS-Dependent NLRP3 Inflammasome-Mediated Pyroptosis in H9C2 Cardiomyocytes. J Diabetes Res. 2019 Feb; 17: 8151836.
19. Tugrul S, Koçyiğit A, Doğan R, Eren SB, Senturk E, Ozturan O, Ozar OF. Total antioxidant status and oxidative stress in recurrent aphthous stomatitis. Int J Dermatol. 2016 Mar; 55 (3): e130-5.
20. Sardaro N, Della Vella F, Incalza MA, DI Stasio D, Lucchese A, Contaldo M, Laudadio C, Petruzzi M. Oxidative Stress and Oral Mucosal Diseases: An Overview. In Vivo. 2019 Mar-Apr; 33 (2): 289-296.
21. DUAN Zhouwei, LI Weiguo, DOU Zhihao, XIE Hui, HE Ai, SHI Min. Extraction and Antioxidant Activity of Flavonoids from Aguilaria sinensis (Lour.) Gilg Leaves. Food Science. 2015, 36 (06): 45-50.
22. Tavares WR, Seca AML. Inula L. Secondary Metabolites against Oxidative Stress-Related Human Diseases. Antioxidants (Basel). 2019 May 6; 8 (5): 122.
23. Draginic N, Jakovljevic V, Andjic M, Jeremic J, Srejovic I, Rankovic M, Tomovic M, Nikolic Turnic T, Svistunov A, Bolevich S, Milosavljevic I. Melissa officinalis L. as a Nutritional Strategy for Cardioprotection. Front Physiol. 2021 Apr 22; 12: 661778.
24. He W, Cao P, Xia Y, Hong L, Zhang T, Shen X, Zheng P, Shen H, Zhao Y, Zou P. Potent inhibition of gastric cancer cells by a natural compound via inhibiting TrxR1 activity and activating ROS-mediated p38 MAPK pathway. Free Radic Res. 2019 Jan; 53 (1): 104-114.
25. Şenel S. An Overview of Physical, Microbiological and Immune Barriers of Oral Mucosa. Int J Mol Sci. 2021 Jul 22; 22 (15): 7821.
26. Capaldo CT, Powell DN, Kalman D. Layered defense: how mucus and tight junctions seal the intestinal barrier. J Mol Med (Berl). 2017 Sep; 95 (9): 927-934.
27. Wang SS, Tang YL, Pang X, Zheng M, Tang YJ, Liang XH. The maintenance of an oral epithelial barrier. Life Sci. 2019 Jun 15; 227: 129-136.
28. Groeger S, Meyle J. Oral Mucosal Epithelial Cells. Front Immunol. 2019 Feb 14; 10: 208.
29. Marunaka Y, Niisato N, Miyazaki H, Nakajima KI, Taruno A, Sun H, Marunaka R, Okui M, Yamamoto T, Kanamura N, Kogiso H, Ikeuchi Y, Kashio M, Hosogi S, Nakahari T. Quercetin is a Useful Medicinal Compound Showing Various Actions Including Control of Blood Pressure, Neurite Elongation and Epithelial Ion Transport. Curr Med Chem. 2018; 25 (37): 4876-4887.
30. Wang X, Cui X, Zhu C, Li M, Zhao J, Shen Z, Shan X, Wang L, Wu H, Shen Y, Ni Y, Zhang D, Zhou G. FKBP11 protects intestinal epithelial cells against inflammation-induced apoptosis via the JNK-caspase pathway in Crohn's disease. Mol Med Rep. 2018 Nov; 18 (5): 4428-4438.
31. Atta AH, Mouneir SM, et al. phytochemical studies and anti-ulcerative colitis effect on moringa oleifera seeds and egyptian propolis methanol extracts in a rat model. Asian Pacific Journal of Tropical Biomedicine, 2019, 9 (3): 98-108.
32. Wang Y, Tang Q, Duan P, Yang L. Curcumin as a therapeutic agent for blocking NF-κB activation in ulcerative colitis. Immunopharmacol Immunotoxicol. 2018 Dec; 40 (6): 476-482.
33. Roda G, Dal Buono A, Argollo M, Danese S. JAK selectivity: more precision less troubles. Expert Rev Gastroenterol Hepatol. 2020 Sep; 14 (9): 789-796.